Prevention and management of viral hepatitis in inflammatory bowel disease: A clinical practice guideline by the korean association for the study of intestinal diseases

for the IBD Research Group of the Korean Association for the Study of Intestinal Diseases

    Research output: Contribution to journalReview articlepeer-review

    15 Citations (Scopus)

    Abstract

    The treatment of inflammatory bowel disease (IBD) has been revolutionized for the last 10 years by the increasing use of immunomodulators and biologics. With immunosuppression of this kind, opportunistic infection is an important safety concern for patients with IBD. In particular, viral hepatitis is determined by the interaction between the virus and the host's immunity, and the risk of reactivation increases if immunity is compromised by immunosuppression therapy. Parts of Asia, including Korea, still show intermediate endemicity for the hepatitis A virus and hepatitis B virus compared with the United States and Western Europe. Thus, members of IBD research group of the Korean Association for the Study of Intestinal Diseases have produced a guideline on the prevention and management of viral hepatitis in IBD.

    Original languageEnglish
    Pages (from-to)18-33
    Number of pages16
    JournalIntestinal Research
    Volume18
    Issue number1
    DOIs
    Publication statusPublished - 2020 Jan 1

    Bibliographical note

    Funding Information:
    We thank members of the Korean Association for the Study of Intestinal Diseases (KASID) and Korean Association for the Study of the Liver (KASL) for their contribution to the agreement voting and reviewing the manuscript.

    Publisher Copyright:
    © 2020. Korean Association for the Study of Intestinal Diseases.

    Keywords

    • Inflammatory bowel disease
    • Prevention
    • Vaccination
    • Viral hepatitis

    ASJC Scopus subject areas

    • Gastroenterology

    Fingerprint

    Dive into the research topics of 'Prevention and management of viral hepatitis in inflammatory bowel disease: A clinical practice guideline by the korean association for the study of intestinal diseases'. Together they form a unique fingerprint.

    Cite this